Grailbio

Menlo Park, US · 2 known investors

GRAIL develops a blood-based multi-cancer early detection test called Galleri that uses next-generation sequencing and machine learning to screen for multiple cancer types before symptoms appear. The company serves healthcare providers, insurers, and patients seeking early cancer detection.